Proteomic approaches to Sjögren's syndrome: A clue to interpret the pathophysiology and organ involvement of the disease

Autoimmunity Reviews

Volumn 9, Issue 9, 2010, Pages 622-626

  Ferraccioli, Gianfranco ^a   De Santis, Maria ^a   Peluso, Giusy ^a   Inzitari, Rosanna ^b   Fanali, Chiara ^b   Bosello, Silvia Laura ^a   Iavarone, Federica ^b   Castagnola, Massimo ^b  

^a Institute of Internal Medicine and Geriatrics   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Proteomics; Sj gren's syndrome

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLASE; AQUAPORIN; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE IV; CLUSTERIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA2; CYTOKERATIN 16; CYTOKERATIN 6; CYTOKERATIN 6B; CYTOKERATIN 6C; DEFENSIN; DEFENSIN BETA2; EPIDERMAL GROWTH FACTOR; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; HLA DR ANTIGEN; INTERFERON RECEPTOR; INTERFERON RECEPTOR 1; INTERLEUKIN 6; KALLIKREIN; LACTOFERRIN; LIPOCALIN; LYSOZYME; MUCIN 5AC; PEROXIDASE; PREALBUMIN; PROLINE RICH PROTEIN; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BRONCHITIS; CLINICAL FEATURE; GENE EXPRESSION REGULATION; HUMAN; INTERSTITIAL LUNG DISEASE; LACRIMAL FLUID; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SALIVA ANALYSIS; SJOEGREN SYNDROME; SYSTEMIC VASCULITIS;

B-LYMPHOCYTES; BIOLOGICAL MARKERS; HUMANS; LACRIMAL APPARATUS; PROTEOMICS; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME; TEARS;

EID: 77954382541     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.010     Document Type: Review

References (40)

1. Fox R.I. Sjögren's syndrome. Lancet 2005, 366:321-331.
2. Hu S., Loo J.A., Wong T.S. Human saliva proteome analysis. Ann NY Acad Sci 2007, 1098:323-329.
3. Baldini C., Giusti L., Bazzichi L., Lucacchini A., Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?. Autoimmun Rev 2008, 7:185-191.
4. Wu T., Mohan C. Proteomic toolbox for autoimmunity research. Autoimmun Rev 2009, 8:595-598.
5. Wilson R., Whitelock J.M., Bateman J.F. Proteomics makes progress in cartilage and arthritis research. Matrix Biol 2009, 28:121-128.
6. Rovin B.H., Birmingham D.J., Nagaraja H.N., Yu C.Y., Hebert L.A. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Joint Dis 2007, 65:187-193.
7. Ryu O.H., Atkinson J.C., Hoen G.T., Illei G.G., Hart T.C. Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45:1077-1086.
8. Giusti L., Baldini C., Bazzichi L., Ciregia F., Tonazzini I., Mascia G., et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases - the example of Sjögren's syndrome. Proteomics 2007, 7:1634-1643.
9. Peluso G., De Santis M., Inzitari R., Fanali C., Cabras T., Messana I., et al. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007, 56:2216-2222.
10. Hu S., Wang J., Meijer J., Ieong S., Xie Y., Yu T., et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007, 56:3588-3600.
11. Hjelmervik T., Jonsson R., Bolstad A.I. The minor salivary gland proteome in Sjögren's syndrome. Oral Dis 2009, 15:342-353.
12. Fleissig Y., Deutsh O., Reichenberg E., Redlich M., Zaks B., Palmon A., et al. Different proteomic protein patterns in saliva of Sjögren's syndrome patients. Oral Dis 2009, 15:61-68.
13. Romeo M.J., Espina V., Lowenthal M., Espina B.H., Petricoin E.F., Liotta L.A. CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics 2005, 2(1):57-70.
14. Janech M.G., Raymond J.R., Arthur J.M. Proteomics in renal research. Am J Physiol Ren Physiol 2007, 292:501-512.
15. Molina H., Bunkenborg J., Reddy G.H., Muthusamy B., Scheel P.J., Pandey A. A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005, 4:637-650.
16. Rottoli P., Bargagli E., Landi C., Magi B. Proteomic analysis in interstitial lung diseases: a review. Curr Opin Pulm Med 2009, 15:470-478.
17. Nielsen P.A., Olsen J.V., Podtelejnikov A.V., Andersen J.R., Mann M., Wisniewski J.R. Proteomic mapping of brain plasma membrane proteins. Mol Cell Proteomics 2005, 4:402-408.
18. Human salivary proteome | chromatography and ionization on a single surface | in-capillary proteolysis | isolating membrane proteins | low-abundance proteins in hemodialysis fluid | high-temperature 2-D LC | gel-free activity-based profiling | new protein cross-linking agents | quantitation of protein phosphorylation | pI shifts aid PTM identification | fluorous proteomics. J Proteome Res 2005;4:659-662.
19. Messana I., Inzitari R., Fanali C., Cabras T., Castagnola M. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us?. J Sep Sci 2008, 31:1948-1963.
20. Messana I., Cabras T., Pisano E., Sanna M.T., Olianas A., Manconi B., et al. Trafficking and post-secretory events responsible for the formation of secreted human salivary peptides. A proteomic approach. Mol Cell Proteomics 2008, 7:911-926.
21. Helmerhorst E.J., Oppenheim F.G. Saliva: a dynamic proteome. J Dent Res 2007, 86:680-693.
22. Hu S., Zhou M., Jiang J., Wang J., Elashoff D., Gorr S., et al. System biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 2009, 60:81-92.
23. Kawasaki S., Kawamoto S., Yokoi N., Connon C., Minesaki Y., Kinoshita S., et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. Exp Eye Res 2003, 77:17-26.
24. Nguyen C., Peck A.B. Unraveling the pathophysiology of Sjögren's syndrome-associated dry eye disease. Lab Sci 2009, 7(1):11-27.
25. Erickson B.E. Tears hold clues to eye disease. J Proteme Res 2005, 4:664.
26. Ohashi Y., Ishida R., Kjima T., Goto E., Matsumoto Y., Watanabe K., et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophtalmol 2003, 136:291-299.
27. Argueso P., Balaram M., Spurr-Michaud S., Keutmann H.T., Dana M.R., Gipson I.K. Decreased levels of the globet cell mucin MUC5AC in tears of patients with Sjögren's syndrome. Investig Ophthalmol Vis Sci 2002, 43:1004-1011.
28. Janssen P.T., van Bijsterveld O.P. Tear fluid proteins in Sjögren's syndrome. Scand J Rheumatol 1986, 61:224-227.
29. Markusse H.M., van Haeringen N.J., Swaak A.J., Smeenk R.T. Tear fluid analysis in primary Sjögren's syndrome. Clin Exp Rheumatol 1993, 11:175-178.
30. Caffery B., Joyce E., Boone A., Slomovic A., Simpson T., Jones L., et al. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye. Optom Vis Sci 2008, 85:661-667.
31. Tomosugi N., Kitagawa K., Takahashi N., Sugai S., Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjögren's syndrome. J Proteome Res 2005, 4:820-825.
32. Li S., Sack R., Vijmasi T., Sathe S., Beaton A., Quigley D., et al. Antibody protein array analysis of tear film cytokines. Optom Vis Sci 2008, 85:653-660.
33. Tzioufas A.G., Voulgarelis M. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007, 21:989-1010.
34. Papiris S.A., Tsonis I.A., Moutsopoulos H.M. Sjögren's syndrome. Semin Respir Crit Care Med 2007, 28:459-471.
35. Ogawa N., Shimoyama K., Kawabata H., Masaki Y., Wano Y., Sugai S. Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders. Ryumachi 2003, 43:19-28.
36. Shimizu Y., Kuwabara H., Ono A., Higuchi S., Hisada T., Dobashi K., et al. Intracellular Th1/Th2 balance of pulmonary CD4(+) T cells in patients with active interstitial pneumonia evaluated by serum KL-6. Immunopharmacol Immunotoxicol 2006, 28:295-304.
37. Shimizu S., Yoshinouchi T., Naniwa T., Nakamura M., Sato S., Ohtsuki Y., et al. Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjögren's syndrome. Virchows Arch 2004, 445:477-484.
38. Baldini C., Giusti L., Bazzichi L., Ciregia F., Giannaccini G., Giacomelli C., et al. Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?. J Rheumatol 2008, 35:1820-1824.
39. Ramos-Casals M., Brito-Zeròn P., Yagüe J., Akasbi M., Bautista R., Ruano M., et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatol 2005, 44:89-94.
40. Turkcapar N., Sak S.D., Saatci M., Duman M., Olmez U. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome. J Rheumatol 2005, 32:1063-1070.